Consistent with previous reports, both anti-MDA5+DM and ASS patients were prone to concurrent ILD, and the incidence of RP-ILD was higher in the MDA5 group, although no statistical difference was found (51.28% vs. 30%, p = 0.120). The gene discussed is IFIH1; the disease is interstitial lung disease.